Johnson & Johnson – Product Pipeline Review – Q2 2011 by GlobalMarketsDirect

VIEWS: 39 PAGES: 370

More Info
									    Johnson & Johnson – Product Pipeline Review – Q2
                         2011
                                                                                          Reference Code: GMDHC1347CDB

                                                                                                Publication Date: AUG 2011




Johnson & Johnson – Product Pipeline Review – Q2 2011                                       GMDHC1347CDB / Published AUG 2011

© Global Markets Direct. This report is a licensed product and is not to be photocopied                                Page(1)
Johnson & Johnson – Product Pipeline Review




Ta b le o f Co n te n ts
Table of Contents                                                                                                     2
List of Tables                                                                                                       16
List of Figures                                                                                                      17
Johnson & Johnson Snapshot                                                                                           18
    Johnson & Johnson Overview                                                                                       18
    Key Information                                                                                                  18
    Key Facts                                                                                                        18
Johnson & Johnson – Research and Development Overview                                                                19
    Key Therapeutic Areas                                                                                            19
Johnson & Johnson – Pipeline Review                                                                                  27
    Pipeline Products by Stage of Development                                                                        27
    Pipeline Products – Monotherapy                                                                                  28
    Pipeline Products – Combination Treatment Modalities                                                             29
Johnson & Johnson – Pipeline Products Glance                                                                         30
    Johnson & Johnson – Late Stage Pipeline                                                                          30
         Registration Filed Products/Combination Treatment Modalities                                                30
         Phase III Products/Combination Treatment Modalities                                                         31
    Johnson & Johnson Clinical Stage Pipeline Products                                                               32
         Phase II Products/Combination Treatment Modalities                                                          32
         Phase I Products/Combination Treatment Modalities                                                           35
    Johnson & Johnson–Early Stage Pipeline Products                                                                  37
         Pre-Clinical Products/Combination Treatment Modalities                                                      37
         Discovery Products/Combination Treatment Modalities                                                         38
Johnson & Johnson – Drug Profiles                                                                                    39
    AAB-002                                                                                                          39
         Product Description                                                                                         39
         Mechanism of Action                                                                                         39
         R&D Progress                                                                                                39
    Abiraterone Acetate + Leuprolide Acetate + Prednisone                                                            40
         Product Description                                                                                         40
         Mechanism of Action                                                                                         40
         R&D Progress                                                                                                40
    Abiraterone Acetate + Prednisone + Leuprolide                                                                    41
         Product Description                                                                                         41
         Mechanism of Action                                                                                         41
         R&D Progress                                                                                                41
    ACC-001                                                                                                          42
         Product Description                                                                                         42
         Mechanism of Action                                                                                         42
         R&D Progress                                                                                                42
    ADX71149                                                                                                         43
         Product Description                                                                                         43
         Mechanism of Action                                                                                         43
         R&D Progress                                                                                                43
    Beta Secretase Inhibitor                                                                                         44
         Product Description                                                                                         44




Johnson & Johnson – Product Pipeline Review – Q2 2011                                     GMDHC1347CDB / Published AUG 2011

©Global Markets Direct.. This report is a licensed product and is not to be photocopied                             Page(2)
Johnson & Johnson – Product Pipeline Review



         Mechanism of Action                                                                                         44
         R&D Progress                                                                                                44
    Carisbamate                                                                                                      45
         Product Description                                                                                         45
         Mechanism of Action                                                                                         45
         R&D Progress                                                                                                45
    CB3304                                                                                                           46
         Product Description                                                                                         46
         Mechanism of Action                                                                                         46
         R&D Progress                                                                                                46
    CB6604                                                                                                           47
         Product Description                                                                                         47
         Mechanism of Action                                                                                         47
         R&D Progress                                                                                                47
    CL184 + Rabies Vaccine                                                                                           48
         Product Description                                                                                         48
         Mechanism of Action                                                                                         48
         R&D Progress                                                                                                48
    CNTO 1959                                                                                                        49
         Product Description                                                                                         49
         Mechanism of Action                                                                                         49
         R&D Progress                                                                                                49
    CNTO 2476                                                                                                        50
         Product Description                                                                                         50
         Mechanism of Action                                                                                         50
         R&D Progress                                                                                                50
    CNTO 3157                                                                                                        51
         Product Description                                                                                         51
         Mechanism of Action                                                                                         51
         R&D Progress                                                                                                51
    CNTO 328 + Mitoxantrone + Prednisone                                                                             52
         Product Description                                                                                         52
         Mechanism of Action                                                                                         52
         R&D Progress                                                                                                52
    CNTO 888                                                                                                         54
         Product Description                                                                                         54
         Mechanism of Action                                                                                         54
         R&D Progress                                                                                                54
    CNTO 888 + Liposomal Doxorubicin Hydrochloride                                                                   55
         Product Description                                                                                         55
         Mechanism of Action                                                                                         55
         R&D Progress                                                                                                55
    CNTO 888 + Docetaxel                                                                                             56
         Product Description                                                                                         56
         Mechanism of Action                                                                                         56
         R&D Progress                                                                                                56
    CNTO 888 + Gemcitabine                                                                                           57
         Product Description                                                                                         57




Johnson & Johnson – Product Pipeline Review – Q2 2011                                     GMDHC1347CDB / Published AUG 2011

©Global Markets Direct.. This report is a licensed product and is not to be photocopied                             Page(3)
Johnson & Johnson – Product Pipeline Review



         Mechanism of Action                                                                                         57
         R&D Progress                                                                                                57
    CNTO 888 + Paclitaxel + Carboplatin                                                                              58
         Product Description                                                                                         58
         Mechanism of Action                                                                                         58
         R&D Progress                                                                                                58
    CNTO 95                                                                                                          59
         Product Description                                                                                         59
         Mechanism of Action                                                                                         59
         R&D Progress                                                                                                59
    CNTO 95 + Docetaxel + Prednisone                                                                                 60
         Product Description                                                                                         60
         Mechanism of Action                                                                                         60
         R&D Progress                                                                                                61
    Crucell Ad35                                                                                                     62
         Product Description                                                                                         62
         Mechanism of Action                                                                                         62
         R&D Progress                                                                                                62
    Dacogen                                                                                                          64
         Product Description                                                                                         64
         Mechanism of Action                                                                                         64
         R&D Progress                                                                                                64
    Dacogen                                                                                          
								
To top